BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11284802)

  • 21. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
    Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
    Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease.
    Hamilos DL; Thawley SE; Kramper MA; Kamil A; Hamid QA
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):79-87. PubMed ID: 9893189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-β1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment.
    Kou W; Hu GH; Yao HB; Wang XQ; Shen Y; Kang HY; Hong SL
    Inflamm Res; 2013 Mar; 62(3):283-9. PubMed ID: 23178794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival.
    Mullol J; Callejas FB; Méndez-Arancibia E; Fuentes M; Alobid I; Martínez-Antón A; Valero A; Picado C; Roca-Ferrer J
    J Biol Regul Homeost Agents; 2010; 24(4):403-11. PubMed ID: 21122279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of allergy on the immunomodulatory and clinical effects of long-term low-dose macrolide treatment of nasal polyposis.
    Peric A; Vojvodic D; Baletic N; Peric A; Miljanovic O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):327-33. PubMed ID: 21293544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis.
    Ding GQ; Zheng CQ; Bagga SS
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1097-103. PubMed ID: 18025312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha.
    Hamilos DL; Leung DY; Wood R; Bean DK; Song YL; Schotman E; Hamid Q
    Am J Respir Cell Mol Biol; 1996 Oct; 15(4):443-50. PubMed ID: 8879177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
    Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
    Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
    Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
    Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune profile modulation of blood and mucosal eosinophils in nasal polyposis with concomitant asthma.
    Mortuaire G; Gengler I; Vandenhende-Szymanski C; Delbeke M; Gatault S; Chevalier D; Prin L; Capron M
    Ann Allergy Asthma Immunol; 2015 Apr; 114(4):299-307.e2. PubMed ID: 25704963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albumin and immunoglobulin levels in nasal secretions of patients with nasal polyps treated with endoscopic sinus surgery and topical corticosteroids.
    Biewenga J; Stoop AE; van der Heijden HA; van der Baan S; van Kamp GJ
    J Allergy Clin Immunol; 1995 Sep; 96(3):334-40. PubMed ID: 7560635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis.
    Scavuzzo MC; Fattori B; Ruffoli R; Rocchi V; Carpi A; Berni R; Giambelluca MA; Giannessi F
    Biomed Pharmacother; 2005 Jul; 59(6):323-9. PubMed ID: 15935609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal inflammation induced by a common cold: comparison between controls and patients with nasal polyposis under topical steroid therapy.
    Dassonville C; Bonfils P; Momas I; Seta N
    Acta Otorhinolaryngol Ital; 2007 Apr; 27(2):78-82. PubMed ID: 17608135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome inhibition reduces proliferation, collagen expression, and inflammatory cytokine production in nasal mucosa and polyp fibroblasts.
    Pujols L; Fernández-Bertolín L; Fuentes-Prado M; Alobid I; Roca-Ferrer J; Agell N; Mullol J; Picado C
    J Pharmacol Exp Ther; 2012 Oct; 343(1):184-97. PubMed ID: 22787116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis.
    Perić A; Vojvodić D; Matković-Jožin S
    J Laryngol Otol; 2012 May; 126(5):495-502. PubMed ID: 22559798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Fluticasone Furoate on Clinical and Immunological Outcomes (IL-17) for Patients With Nasal Polyposis Naive to Steroid Treatment.
    Venkatesan N; Lavigne P; Lavigne F; Hamid Q
    Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):213-8. PubMed ID: 26405064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cytokines in nasal polyposis.
    Singh H; Ballow M
    J Investig Allergol Clin Immunol; 2003; 13(1):6-11. PubMed ID: 12861845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.
    Martínez-Antón A; de Bolós C; Alobid I; Benítez P; Roca-Ferrer J; Picado C; Mullol J
    Allergy; 2008 Oct; 63(10):1368-76. PubMed ID: 18547287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Chen D; Mao M; Bellussi LM; Passali D; Chen L
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.